📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis. (2021)

First Author: He S

Attributed to: Technologies for the Treatment of Brain Diseases funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.cellsig.2021.109931

PubMed Identifier: 33529758

Publication URI: http://europepmc.org/abstract/MED/33529758

Type: Journal Article/Review

Volume: 81

Parent Publication: Cellular signalling

ISSN: 0898-6568